## **Core Concept**
The management of bleeding oesophageal varices primarily involves the use of medications that reduce portal pressure or treat the varices directly. Pharmacological interventions aim to decrease the risk of rebleeding and mortality.

## **Why the Correct Answer is Right**
Terlipressin (option ) is a synthetic analogue of vasopressin and is considered a first-line treatment for acute variceal bleeding, particularly for oesophageal varices. It works by causing vasoconstriction of the splanchnic circulation, thereby reducing portal pressure. This action helps to control bleeding from oesophageal varices. Terlipressin has a longer duration of action and fewer side effects compared to vasopressin, making it a preferred choice.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is not typically used as a first-line treatment for acute bleeding oesophageal varices. While it can reduce portal pressure, it's not as commonly used or as effective as terlipressin in this setting.
- **Option B:** is used in the management of portal hypertension and variceal bleeding but is more commonly associated with long-term reduction of portal pressure and prevention of variceal bleeding rather than acute management.
- **Option D:** is not typically used for the acute management of bleeding oesophageal varices. It might be considered in certain cases but is not the drug of choice.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that for acute variceal bleeding, especially from oesophageal varices, the initial management includes the use of vasoactive drugs like terlipressin, alongside endoscopic therapy (e.g., variceal ligation). This approach has been shown to improve outcomes.

## **Correct Answer:** . Terlipressin